## XYL: Xylem Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 0.6% below STRENGTH zone (4.0-10.0%); PEG 2.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($135.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Xylem (XYL) Analyst Rating Update: Mizuho Lowers Price Target**
- Source: GuruFocus | 20260105T144454 | Somewhat-Bearish | Relevance: 100%
- Mizuho has reiterated a Neutral rating on Xylem (XYL) but reduced its price target from $160 to $150, representing a 6.25% decrease. This decision comes after several other analysts had raised their price targets for Xylem in late 2025. Xylem, a global leader in water technology, generated $8.6 billion in revenue in 2024, and Wall Street analysts currently forecast an average target price of $167.26 for the stock, indicating a potential upside of 21.99% from its current price.

**2. TSP Capital Management Group LLC Sells 11,701 Shares of Xylem Inc. $XYL**
- Source: MarketBeat | 20260105T130850 | Somewhat-Bullish | Relevance: 100%
- TSP Capital Management Group LLC reduced its stake in Xylem Inc. by 11.7% in the third quarter, selling 11,701 shares and decreasing its position to 88,232 shares valued at $13.01 million. Despite this, Xylem announced a quarterly dividend and analysts maintain a "Moderate Buy" rating with an average target price of $167.40, following strong Q3 earnings that surpassed expectations. Insider activity also saw executives selling shares, though institutional ownership remains high at 87.96%.

**3. Allspring Global Investments Holdings LLC Acquires 66,018 Shares of Xylem Inc. $XYL**
- Source: MarketBeat | 20260104T080834 | Bullish | Relevance: 100%
- Allspring Global Investments Holdings LLC increased its stake in Xylem Inc. by 65.0% in Q3, acquiring an additional 66,018 shares to a total of 167,572 shares, valued at approximately $24.78 million. Xylem Inc. has a "Moderate Buy" consensus rating from analysts with an average price target of $167.40, following strong Q3 earnings where the company beat EPS estimates and provided positive FY2025 guidance. The company also announced a quarterly dividend of $0.40 per share, representing an annualized yield of 1.2%.

**4. Lab automation specialist Scinomix joins Ingersoll Randâ€™s life sciences arm**
- Source: Stock Titan | 20260105T213157 | Neutral | Relevance: 64%
- Ingersoll Rand (NYSE: IR) has acquired Scinomix, a U.S.-based designer and manufacturer of lab automation technologies, to expand its life sciences portfolio. This acquisition integrates Scinomix into Ingersoll Rand's Precision and Science Technologies Life Sciences platform, aiming to provide comprehensive, end-to-end solutions for sample management and lab equipment automation. The deal was made at an attractive pre-synergy multiple of approximately 10x 2025 Adjusted EBITDA.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Mizuho | $150 | $160 | -6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Mizuho | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.7%)
- Blackrock Inc.: 10.2% (+1.6%)
- State Street Corpora: 4.5% (+1.2%)
- Geode Capital Manage: 2.5% (+1.1%)
- Impax Asset Manageme: 2.2% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +1.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.08 elevated, pricing in significant growth expectations. Forward P/E 25.0x stretched relative to 10% growth. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $33.8B |
| Beta | 1.17 |
| 52W Range | $100.47 - $154.27 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.08 |
| Forward P/E | 25.0 |
| Current P/E | 27.5 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.5% to 0.6% (+1.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.4pp (needs >4.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. RSI neutral at 49. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.57% (CS: 49) | Neutral |
| RSI_14 | 49.3 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 0.975x | Below |
| vs SMA200 | 1.036x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $139.04
- **Stop Loss:** $135.02 (2.9% risk)
- **Target:** $143.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 343
- **Position Value:** $47,690.72
- **Portfolio %:** 47.69%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-03 (Est: $1.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.37 | +11.1% |
| 2025Q2 | $1.15 | $1.26 | +9.9% |
| 2025Q1 | $0.95 | $1.03 | +8.0% |
| 2024Q4 | $1.13 | $1.18 | +4.9% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*